Reuters logo
BRIEF-Admedus updates on Admedus Immunotherapies (AI) funding
November 1, 2017 / 10:18 PM / 22 days ago

BRIEF-Admedus updates on Admedus Immunotherapies (AI) funding

Nov 2 (Reuters) - Admedus Ltd

* ‍Notes recent media speculation about ongoing funding of Admedus Vaccines Pty Ltd and Admedus Immunotherapies (AI) business run by it​

* Confirms ‍there has been no change in Co’s approach to AI to that previously disclosed to ASX​

* Notes Admedus Immunotherapies does not contribute to co’s revenue in a material way​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below